An ethical hierarchy for decision making during medical emergencies

Annals of Neurology

Volumn 67, Issue 4, 2010, Pages 434-440

  Lyden, Patrick D ^a,b   Meyer, Brett C ^a   Hemmen, Thomas M ^a   Rapp, Karen S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; EMBOLECTOMY; EMERGENCY TREATMENT; EVIDENCE BASED PRACTICE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE;

ADULT; CLINICAL TRIALS AS TOPIC; DECISION MAKING; DIFFUSION MAGNETIC RESONANCE IMAGING; EMERGENCIES; HUMANS; MALE; PARESIS; PATIENT PARTICIPATION; PHYSICIANS;

EID: 77951705517     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21997     Document Type: Article

References (26)

1. Kaplan RM, Frosch DL. Decision making in medicine and health care. Annu Rev Clin Psychol 2005;1:525-556. (Pubitemid 43843961)
2. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003;327:1459-1461.
3. Mandava P, Kent TA. Intra-arterial therapies for acute ischemic stroke. Neurology 2007;68:2132-2139. (Pubitemid 46912133)
4. Brown ML, Gersh BJ, Holmes DR, et al. From randomized trials to registry studies: translating data into clinical information. Nat Clin Pract Cardiovasc Med 2008;5:613-620.
5. London AJ. The ambiguity and the exigency: clarifying "standard of care" arguments in international research. J Med Philos 2000; 25:379-397.
6. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 2005;365:82-93.
7. Caplan LR. How well does "evidence-based" medicine help neurologists care for individual patients? Rev Neurol Dis 2007;4: 75-84.
8. Fried C. Medical experimentation: personal integrity and social policy. New York, NY: American Elsevier Publishing, 1974.
9. Kharitonova T, Ahmed N, Thoren M, et al. Hyperdense middle cerebral artery sign on admission CT scan - prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 2009;27:51-59.
10. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768.
11. Berlin JA, Glasser SC, Ellenberg SS. Adverse event detection in drug development: recommendations and obligations beyond phase 3. Am J Public Health 2008;98:1366-1371.
12. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351:1891-1900.
13. Wahlgren N, Ahmed N, Eriksson N, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITSMOST). Stroke 2008;39:3316-3322.
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
15. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
16. Yusuf S. Randomised controlled trials in cardiovascular medicine: past achievements, future challenges. BMJ 1999;319:564-568. (Pubitemid 29403642)
17. Howard G. Nonconventional clinical trial designs: approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost. Stroke 2007;38:804-808. (Pubitemid 46184263)
18. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol 2001;54:217-224.
19. Vist GE, Bryant D, Somerville L, et al. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev 2008;(3):MR000009. (Pubitemid 351835428)
20. National Institute of Neurological Disorders and Stroke Stroke and Trauma Division. North American Symptomatic Carotid Endarterectomy Trial (NASCET) investigators. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. Stroke 1991;22:816-817.
21. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-517. (Pubitemid 44871793)
22. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141-150.
23. Schaefer GO, Emanuel EJ, Wertheimer A. The obligation to participate in biomedical research. JAMA 2009;302:67-72.
24. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20:21-35. (Pubitemid 33732964)
25. Kaplan AV, Harvey ED, Kuntz RE, et al. Humanitarian Use Devices/Humanitarian Device Exemptions in cardiovascular medicine. Circulation 2005;112:2883-2886.
26. Bloche MG. Clinical loyalties and the social purposes of medicine. JAMA 1999;281:268-274.